Similar articles

• Prostate cancer and prostatic intraepithelial neoplasia: true, true, and unrelated?

  Thompson IM Jr, Leach R. Thompson IM Jr, et al. J Clin Oncol. 2013 Feb 10;31(5):515-6. doi: 10.1200/JCO.2012.46.6151. Epub 2013 Jan 7. J Clin Oncol. 2013. PMID: 23295801 No abstract available.
• Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.

  Taneja SS, Morton R, Barnette G, Sieber P, Hancock ML, Steiner M. Taneja SS, et al. J Clin Oncol. 2013 Feb 10;31(5):523-9. doi: 10.1200/JCO.2012.41.7634. Epub 2013 Jan 7. J Clin Oncol. 2013. PMID: 23295793 Clinical Trial.
• Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia.

  Steiner MS, Pound CR. Steiner MS, et al. Clin Prostate Cancer. 2003 Jun;2(1):24-31. doi: 10.3816/cgc.2003.n.009. Clin Prostate Cancer. 2003. PMID: 15046680 Clinical Trial.
• Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy.

  Taneja SS, Smith MR, Dalton JT, Raghow S, Barnette G, Steiner M, Veverka KA. Taneja SS, et al. Expert Opin Investig Drugs. 2006 Mar;15(3):293-305. doi: 10.1517/13543784.15.3.293. Expert Opin Investig Drugs. 2006. PMID: 16503765 Review.
• Androgen deprivation therapy for precancerous lesions of the prostate.

  Hull D, Bostwick DG. Hull D, et al. Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):285-91. doi: 10.1016/j.beem.2008.01.006. Best Pract Res Clin Endocrinol Metab. 2008. PMID: 18471786 Review.